EPISODE · Nov 19, 2021 · 1H 1M
OsteoBites: Clinical Trials for Relapsed or Refractory Osteosarcoma - The OLIE Study and Beyond!
from MIB Agents OsteoBites and osTEAo · host MIB Agents Osteosarcoma
Join Dr Filemon Dela Cruz & Dr. Julia Glade Bender as they talk about The OLIE Study - Evaluating lenvatinib in combination with chemotherapy for relapsed or refractory osteosarcoma. ...... Organization Memorial Sloan Kettering Cancer Center/MSK Kids What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard LINKS: OLIE Clinical Trial: LINK 🔗Memorial Sloan Kettering Cancer Center Pediatrics: LINK 📧 Filemon Dela Cruz, MD: [email protected] 📧 Julia Glade-Bender, MD: [email protected] 🔗MIB Clinical Trial Finder In 60 seconds: LINK 🔗 MIB Programs: LINK 🔗 MIB Osteosarcoma FACTOR: LINK 🔗 MIB Osteosarcoma Research: LINK ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org 🔗Donate HERE ✨✨SUBSCRIBE for all the Osteosarcoma Intel ✨✨
Embed this episode
NOW PLAYING
OsteoBites: Clinical Trials for Relapsed or Refractory Osteosarcoma - The OLIE Study and Beyond!
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.